Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma

<p>Differentially methylated regions with at least five CpGs, and a mean difference of greater than 20% between day 14 and baseline white blood cells</p>

Kaydedildi:

Detaylı Bibliyografya
Yazar:	John A. Ligon (15024477) (author)
Diğer Yazarlar:	R. Taylor Sundby (15049851) (author), Mary F. Wedekind (15049854) (author), Fernanda I. Arnaldez (15049857) (author), Jaydira Del Rivero (15049860) (author), Lori Wiener (15049863) (author), Ramaprasad Srinivasan (15049866) (author), Melissa Spencer (15049869) (author), Amanda Carbonell (15049872) (author), Haiyan Lei (14963261) (author), John Shern (15049875) (author), Seth M. Steinberg (15043179) (author), William D. Figg (15017625) (author), Cody J. Peer (14946853) (author), Sara Zimmerman (15049878) (author), Josquin Moraly (15049881) (author), Xia Xu (15049884) (author), Stephen Fox (15049887) (author), King Chan (15049890) (author), Michael I. Barbato (15049893) (author), Thorkell Andresson (15049896) (author), Naomi Taylor (15049899) (author), Karel Pacak (15049902) (author), J. Keith Killian (15049905) (author), Eva Dombi (14942359) (author), W. Marston Linehan (15049908) (author), Markku Miettinen (15049911) (author), Richard Piekarz (15035022) (author), Lee J. Helman (15049914) (author), Paul Meltzer (14956444) (author), Brigitte Widemann (15049917) (author), John Glod (15049920) (author)
Baskı/Yayın Bilgisi:	2025
Konular:	Cancer Clinical Research and Trials Clinical Trial Results Phase II clinical trials Endocrine-Related Cancers Gastrointestinal Cancers Sarcomas
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!

_version_	1849927634252726272
author	John A. Ligon (15024477)
author2	R. Taylor Sundby (15049851) Mary F. Wedekind (15049854) Fernanda I. Arnaldez (15049857) Jaydira Del Rivero (15049860) Lori Wiener (15049863) Ramaprasad Srinivasan (15049866) Melissa Spencer (15049869) Amanda Carbonell (15049872) Haiyan Lei (14963261) John Shern (15049875) Seth M. Steinberg (15043179) William D. Figg (15017625) Cody J. Peer (14946853) Sara Zimmerman (15049878) Josquin Moraly (15049881) Xia Xu (15049884) Stephen Fox (15049887) King Chan (15049890) Michael I. Barbato (15049893) Thorkell Andresson (15049896) Naomi Taylor (15049899) Karel Pacak (15049902) J. Keith Killian (15049905) Eva Dombi (14942359) W. Marston Linehan (15049908) Markku Miettinen (15049911) Richard Piekarz (15035022) Lee J. Helman (15049914) Paul Meltzer (14956444) Brigitte Widemann (15049917) John Glod (15049920)
author2_role	author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author author
author_facet	John A. Ligon (15024477) R. Taylor Sundby (15049851) Mary F. Wedekind (15049854) Fernanda I. Arnaldez (15049857) Jaydira Del Rivero (15049860) Lori Wiener (15049863) Ramaprasad Srinivasan (15049866) Melissa Spencer (15049869) Amanda Carbonell (15049872) Haiyan Lei (14963261) John Shern (15049875) Seth M. Steinberg (15043179) William D. Figg (15017625) Cody J. Peer (14946853) Sara Zimmerman (15049878) Josquin Moraly (15049881) Xia Xu (15049884) Stephen Fox (15049887) King Chan (15049890) Michael I. Barbato (15049893) Thorkell Andresson (15049896) Naomi Taylor (15049899) Karel Pacak (15049902) J. Keith Killian (15049905) Eva Dombi (14942359) W. Marston Linehan (15049908) Markku Miettinen (15049911) Richard Piekarz (15035022) Lee J. Helman (15049914) Paul Meltzer (14956444) Brigitte Widemann (15049917) John Glod (15049920)
author_role	author
dc.creator.none.fl_str_mv	John A. Ligon (15024477) R. Taylor Sundby (15049851) Mary F. Wedekind (15049854) Fernanda I. Arnaldez (15049857) Jaydira Del Rivero (15049860) Lori Wiener (15049863) Ramaprasad Srinivasan (15049866) Melissa Spencer (15049869) Amanda Carbonell (15049872) Haiyan Lei (14963261) John Shern (15049875) Seth M. Steinberg (15043179) William D. Figg (15017625) Cody J. Peer (14946853) Sara Zimmerman (15049878) Josquin Moraly (15049881) Xia Xu (15049884) Stephen Fox (15049887) King Chan (15049890) Michael I. Barbato (15049893) Thorkell Andresson (15049896) Naomi Taylor (15049899) Karel Pacak (15049902) J. Keith Killian (15049905) Eva Dombi (14942359) W. Marston Linehan (15049908) Markku Miettinen (15049911) Richard Piekarz (15035022) Lee J. Helman (15049914) Paul Meltzer (14956444) Brigitte Widemann (15049917) John Glod (15049920)
dc.date.none.fl_str_mv	2025-11-25T12:43:38Z
dc.identifier.none.fl_str_mv	10.1158/1078-0432.30705968
dc.relation.none.fl_str_mv	https://figshare.com/articles/dataset/Supplementary_Table_S2_from_A_Phase_II_Trial_of_Guadecitabine_in_Children_and_Adults_with_SDH-Deficient_GIST_Pheochromocytoma_Paraganglioma_and_HLRCC-Associated_Renal_Cell_Carcinoma/30705968
dc.rights.none.fl_str_mv	CC BY info:eu-repo/semantics/openAccess
dc.subject.none.fl_str_mv	Cancer Clinical Research and Trials Clinical Trial Results Phase II clinical trials Endocrine-Related Cancers Gastrointestinal Cancers Sarcomas
dc.title.none.fl_str_mv	Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
dc.type.none.fl_str_mv	Dataset info:eu-repo/semantics/publishedVersion dataset
description	<p>Differentially methylated regions with at least five CpGs, and a mean difference of greater than 20% between day 14 and baseline white blood cells</p>
eu_rights_str_mv	openAccess
id	Manara_cc45bb47a81e5c616adf9ed63b5234fd
identifier_str_mv	10.1158/1078-0432.30705968
network_acronym_str	Manara
network_name_str	ManaraRepo
oai_identifier_str	oai:figshare.com:article/30705968
publishDate	2025
repository.mail.fl_str_mv
repository.name.fl_str_mv
repository_id_str
rights_invalid_str_mv	CC BY
spelling	Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell CarcinomaJohn A. Ligon (15024477)R. Taylor Sundby (15049851)Mary F. Wedekind (15049854)Fernanda I. Arnaldez (15049857)Jaydira Del Rivero (15049860)Lori Wiener (15049863)Ramaprasad Srinivasan (15049866)Melissa Spencer (15049869)Amanda Carbonell (15049872)Haiyan Lei (14963261)John Shern (15049875)Seth M. Steinberg (15043179)William D. Figg (15017625)Cody J. Peer (14946853)Sara Zimmerman (15049878)Josquin Moraly (15049881)Xia Xu (15049884)Stephen Fox (15049887)King Chan (15049890)Michael I. Barbato (15049893)Thorkell Andresson (15049896)Naomi Taylor (15049899)Karel Pacak (15049902)J. Keith Killian (15049905)Eva Dombi (14942359)W. Marston Linehan (15049908)Markku Miettinen (15049911)Richard Piekarz (15035022)Lee J. Helman (15049914)Paul Meltzer (14956444)Brigitte Widemann (15049917)John Glod (15049920)CancerClinical Research and TrialsClinical Trial ResultsPhase II clinical trialsEndocrine-Related CancersGastrointestinal CancersSarcomas<p>Differentially methylated regions with at least five CpGs, and a mean difference of greater than 20% between day 14 and baseline white blood cells</p>2025-11-25T12:43:38ZDatasetinfo:eu-repo/semantics/publishedVersiondataset10.1158/1078-0432.30705968https://figshare.com/articles/dataset/Supplementary_Table_S2_from_A_Phase_II_Trial_of_Guadecitabine_in_Children_and_Adults_with_SDH-Deficient_GIST_Pheochromocytoma_Paraganglioma_and_HLRCC-Associated_Renal_Cell_Carcinoma/30705968CC BYinfo:eu-repo/semantics/openAccessoai:figshare.com:article/307059682025-11-25T12:43:38Z
spellingShingle	Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma John A. Ligon (15024477) Cancer Clinical Research and Trials Clinical Trial Results Phase II clinical trials Endocrine-Related Cancers Gastrointestinal Cancers Sarcomas
status_str	publishedVersion
title	Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
title_full	Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
title_fullStr	Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
title_full_unstemmed	Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
title_short	Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
title_sort	Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
topic	Cancer Clinical Research and Trials Clinical Trial Results Phase II clinical trials Endocrine-Related Cancers Gastrointestinal Cancers Sarcomas

Supplementary Table S2 from A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma

Benzer Materyaller